Publicacións en colaboración con investigadores/as de Universidad de Navarra (40)

2022

  1. Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

  2. Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss

    Archives of Medical Science, Vol. 18, Núm. 1, pp. 36-44

  3. Immunomodulatory effect of a very-low-calorie ketogenic diet compared with bariatric surgery and a low-calorie diet in patients with excessive body weight

    Clinical Nutrition, Vol. 41, Núm. 7, pp. 1566-1577

2021

  1. Epigenetic landscape in blood leukocytes following ketosis and weight loss induced by a very low calorie ketogenic diet (VLCKD) in patients with obesity

    Clinical Nutrition, Vol. 40, Núm. 6, pp. 3959-3972

  2. Transdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes

    Nutrients, Vol. 13, Núm. 12

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity

    Nutrients, Vol. 11, Núm. 10

  3. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

  2. DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: A genome-wide analysis from non-obese and obese patients

    Scientific Reports, Vol. 7

  3. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: A marker of metabolic stress?

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1570-1578

  4. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2

  2. Decision making impairment: A shared vulnerability in obesity, gambling disorder and substance use disorders?

    PLoS ONE, Vol. 11, Núm. 9

  3. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 523-527

  4. Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits

    Molecular Nutrition and Food Research, Vol. 60, Núm. 7, pp. 1673-1683

  5. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 510-517

  6. Interplay of atherogenic factors, protein intake and betatrophin levels in obese-metabolic syndrome patients treated with hypocaloric diets

    International Journal of Obesity, Vol. 40, Núm. 3, pp. 403-410

  7. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity

    Scientific Reports, Vol. 6

  8. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome

    Psychoneuroendocrinology, Vol. 65, pp. 102-108